The three MACE components, CV mortality (reduced by 13%), non-fatal stroke (reduced by 16%), and non-fatal MI (reduced by 9%, although the level of reduction was not statistically significant), are likewise decreased by GLP-1 RA. Here, GLP1R is linked to Stroke.